Migraine drug to be available OTC in England
The Medicines and Healthcare Products Regulatory Agency, London,has announced that the migraine medication sumatriptan (Imigran) isto be reclassified from Prescription Only Medicine (POM) toPharmacy Medicine (P) status, making it available from pharmacieswithout the need for a prescription. With England setting aprecedent, will the United States be next?
The Medicines and Healthcare Products Regulatory Agency, London, has announced that the migraine medication sumatriptan (Imigran) is to be reclassified from Prescription Only Medicine (POM) to Pharmacy Medicine (P) status, making it available from pharmacies without the need for a prescription. With England setting a precedent, will the United States be next?
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
